PrP(ST), a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease

Por Friedman-Levi, Yael, Mizrahi, Michal, Frid, Kati, Binyamin, Orli, Gabizon, Ruth
Publicado em 2013

Correction: PrP(ST), a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease

Por Friedman-Levi, Yael, Mizrahi, Michal, Frid, Kati, Binyamin, Orli, Gabizon, Ruth
Publicado no PLoS One (2015)

Aggregation of MBP in chronic demyelination

Por Frid, Kati, Einstein, Ofira, Friedman-Levi, Yael, Binyamin, Orli, Ben-Hur, Tamir, Gabizon, Ruth
Publicado no Ann Clin Transl Neurol (2015)

Chronic Progressive Neurodegeneration in a Transgenic Mouse Model of Prion Disease

Por Fainstein, Nina, Dori, Dvir, Frid, Kati, Fritz, Alexa T., Shapiro, Ilona, Gabizon, Ruth, Ben-Hur, Tamir
Publicado no Front Neurosci (2016)

Oxidation of Helix-3 Methionines Precedes the Formation of PK Resistant PrP(Sc)

Por Canello, Tamar, Frid, Kati, Gabizon, Ronen, Lisa, Silvia, Friedler, Assaf, Moskovitz, Jackob, Gasset, María, Gabizon, Ruth
Publicado em 2010

Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease

Por Friedman-Levi, Yael, Meiner, Zeev, Canello, Tamar, Frid, Kati, Kovacs, Gabor G., Budka, Herbert, Avrahami, Dana, Gabizon, Ruth
Publicado em 2011

Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant

Por Binyamin, Orli, Larush, Liraz, Frid, Kati, Keller, Guy, Friedman-Levi, Yael, Ovadia, Haim, Abramsky, Oded, Magdassi, Shlomo, Gabizon, Ruth
Publicado no Int J Nanomedicine (2015)

Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression

Por Cohen, Eran, Avrahami, Dana, Frid, Kati, Canello, Tamar, Levy Lahad, Ephrat, Zeligson, Sharon, Perlberg, Shira, Chapman, Joab, Cohen, Oren S., Kahana, Esther, Lavon, Iris, Gabizon, Ruth
Publicado em 2013